Alembic says it received tentative USFDA nod for its anti-cardiac stroke medicine
This drug has an estimated market size of $465 million for twelve months ending December 2021
Tata Neu Dabigatran Etexilate Boehringer Ingelheim Pharmaceuticals Alembic Pharmaceuticals Limited On Us Food Drug Administration Alembic Pharmaceuticals Limited
Source: businesstoday.in